Author:
Corboz Michel R.,Salvail William,Gagnon Sandra,LaSala Daniel,Laurent Charles E.,Salvail Dany,Chen Kuan-Ju,Cipolla David,Perkins Walter R.,Chapman Richard W.
Subject
Cell Biology,Pharmacology,Physiology,Biochemistry
Reference67 articles.
1. The pharmacological treatment of pulmonary arterial hypertension;Frumkin;Pharmacol. Rev.,2012
2. Prostacyclin therapies for the treatment of pulmonary arterial hypertension;Gomberg-Maitland;Eur. Respir. J.,2008
3. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist;Whittle;Biochem. Pharmacol.,2012
4. International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress;Woodward;Pharmacol. Rev.,2011
5. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin;Moncada;Pharmacol. Rev.,1978